NDC 59762-0058-01 - medroxyprogesterone acetate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59762-0058
- Requested NDC
- 59762-0058-01
- Package NDCs from labels
- 59762-0058-1, 59762-0058-2, 59762-0058-01
- Manufacturer
- Mylan Pharmaceuticals Inc. | Pfizer Inc | Pharmacia & Upjohn Company LLC | Pfizer Italia S.r.l.
- Effective date
- 2026-05-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Medroxyprogesterone Acetate Tablets, USP | Mylan Pharmaceuticals Inc. | Pfizer Inc | Pharmacia & Upjohn Company LLC | Pfizer Italia S.r.l. | 2026-05-21 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59762-0058-1 | medroxyprogesterone acetate | 100 in 1 BOTTLE | TABLET | 100 | 33 | |
| 59762-0058-2 | medroxyprogesterone acetate | 1000 in 1 BOTTLE | TABLET | 1000 | 33 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59762-0058 | MEDROXYPROGESTERONE ACETATE TABLET [MYLAN PHARMACEUTICALS INC.] | 32 | Current NDC, Legacy NDC, 2 package rows | 20250523_2627eb11-06bf-4a45-9172-094468e3ca07.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59762-0058-1 | EA - Each | 59762-0058 | 74824a06-4a73-42ec-9ca7-b0c406fd5335 | 1 | 2019-01-24 |
| 59762-0058-2 | EA - Each | 59762-0058 | 9b9c7c7c-7cd2-4707-8811-c4144d961d02 | 1 | 2020-04-20 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Northwind Health Company, LLC | 0de6142f-a78e-ae58-e063-6394a90adff0 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 1000114 C2QI4IOI2G |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Amphastar Pharmaceuticals, Inc. | fda1aa8a-5739-482a-b4f6-9741ef4d9977 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| B03 Sinus Relief | ALLIUM CEPA, CALCAREA IODATA, CALCAREA SULPHURICA, ECHINACEA ANGUSTIFOLIA, ECHINACEA PURPUREA, EUPHORBIUM OFFICINARUM, HEPAR SULPHURIS CALCAREUM, HISTAMINUM HYDROCHLORICUM, HYDRASTIS CANADENSIS, KALI BICHROMICUM, KALI MURIATICUM, KALI SULPHURICUM, LAC DEFLORATUM, LUFFA OPERCULATA, MERCURIUS SULPHURATUS RUBER, PHOSPHORUS, PULSATILLA VULGARIS, SACCHARUM LACTIS, THUJA OCCIDENTALIS | Apex Energetics Inc. | bad83f77-e9ae-7118-e053-2a95a90aa737 | 2025-12-31 | Warnings | J2B2A4N98G |
| Medicated Cornstarch Baby Powder | ACTIVE CORN STARCH | Davion, Inc. | e39032d1-c8cd-4a41-af10-126970b8ad38 | 2025-12-29 | Warnings | O8232NY3SJ |
| HEMORRHOIDAL | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HYDROCHLORIDE | Safeway | 3e6728b6-26e3-4287-8ba6-e27f305cd93b | 2025-12-20 | Warnings | T5L8T28FGP |
| Depo-SubQ Provera | MEDROXYPROGESTERONE ACETATE | Pharmacia & Upjohn Company LLC | 390087a6-f3c3-4f0b-a930-79acf412f153 | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | C2QI4IOI2G |
| CAREALL Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | New World Imports, Inc | 7913bd41-a606-4ca6-b69f-2717c2f54b07 | 2025-12-01 | Warnings | T5L8T28FGP |
| HOEGOA Hair Scalp Sunscreen Mineral | TITANIUM DIOXIDE | Guangzhou Hoegoa Biotechnology Co., Ltd. | 44b37930-b302-338c-e063-6394a90a5f7f | 2025-11-28 | Warnings | T5L8T28FGP |
| OUHOE Biotin With Hydrolyzed Collagen | GLYCERIN | Shantou Ouhoe Technology Co., Ltd. | 43138915-5fe1-6e32-e063-6294a90abefa | 2025-11-27 | Warnings | T5L8T28FGP |
| GNP Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE, HCL | Amerisource Bergen | b0f0ef97-9add-717f-e053-2a95a90a0eb0 | 2025-10-30 | Warnings | T5L8T28FGP |
| Winco Hemorrhoidal | MINERAL OIL, PETROLATUM, AND PHENYLEPHRINE HYDROCHLORIDE | Winco Foods, LLC | 04ca3ef1-fc6b-4683-b236-a75afc031fb5 | 2025-10-23 | Warnings | T5L8T28FGP |
| Family Care Hemorrhoidal | MINERAL OIL | United Exchange Corp | 04375257-f4f3-48c3-a338-de43298b95eb | 2025-10-22 | Warnings | T5L8T28FGP |
| Family Wellness Hemorrhoidal | MINERAL OIL, PETROLATUM, AND PHENYLEPHRINE HCL | Family Dollar Services, Inc | fe3293bc-80b5-b60a-e053-6394a90a4ede | 2025-10-22 | Warnings | T5L8T28FGP |
| Sugar Cravings | CINNAMIC ACID, PHLORIDZINUM, ARGENTUM NITRICUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, BEET SUGAR, DEXTROSE, D-RIBOSE, FRUCTOSE, LYCOPODIUM CLAVATUM, MAPLE SUGAR, SACCHARUM LACTIS, SACCHARUM OFFICINALE, SARCOLACTICUM ACIDUM, MALVIN, ADRENOCORTICOTROPHIN, DYSENTERY BACILLUS, MORGAN GAERTNER | Dr. Donna Restivo DC | 401873ba-ae1b-4506-a2e8-c6c0e5ff27f5 | 2025-10-21 | Warnings | C151H8M554 J2B2A4N98G |
| Leader Ready to Use Mineral Oil Laxative | MINERAL OIL | Cardinal Health | b8494d02-8a7d-47b4-80b0-b8ab51b625fd | 2025-09-29 | Warnings | T5L8T28FGP |
| Exchange Select Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Army & Air Force Exchange Service | 6c32af3e-5b60-4e3e-95c2-ada37a7d3b2a | 2025-08-22 | Warnings | T5L8T28FGP |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Padagis Israel Pharmaceuticals Ltd | 43826c68-0a20-460d-a7b5-f3e12395a7d0 | 2025-08-22 | Warnings | T5L8T28FGP |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Publix Super Markets Inc | 7b360d3b-fb2b-4f35-a04d-203dd352933d | 2025-08-19 | Warnings | T5L8T28FGP |
| Good Sense Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | L. Perrigo Company | 2492ee1b-01f1-46e7-8790-b6ebc48f2aff | 2025-08-19 | Warnings | T5L8T28FGP |
| DG Health Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Dolgencorp, LLC | d9f12a34-7bd1-4ba5-b34b-1b641f58271a | 2025-08-12 | Warnings | T5L8T28FGP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.